These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 6536653)
21. T-inducer lymphocytes, leukapheresis and the pathogenesis of rheumatoid arthritis. Wilder RL; Decker JL Clin Exp Rheumatol; 1983; 1(2):89-91. PubMed ID: 6241855 [No Abstract] [Full Text] [Related]
22. Lymphocyte subpopulations and immunoglobulins in blood in rheumatoid arthritis. Kapoor AK; Khan IU; Tuteja N; Dash UC; Jain UK; Siddiqui JS; Singh M; Bhushan V; Mehrotra RM; Bahuguna LM Indian J Med Res; 1981 Oct; 74():595-9. PubMed ID: 7338385 [No Abstract] [Full Text] [Related]
23. [Lymphocytopheresis and plasmapheresis in rheumatoid arthritis]. Dubrovina NA; Kalinin NN; Khotinian RI; Molchanova NP; Petrov MM Revmatologiia (Mosk); 1984; (3):9-12. PubMed ID: 6390635 [No Abstract] [Full Text] [Related]
24. An update on the status of the treatment of rheumatoid arthritis by lymphapheresis. Karsh J Int J Artif Organs; 1985 Jul; 8 Suppl 2():35-8. PubMed ID: 3876998 [No Abstract] [Full Text] [Related]
25. Immune function in blood donors following short-term lymphocytapheresis. Blanchette VS; Dunne J; Steele D; McPhail S; Sklar S; Algom D; Richter MA; Rock G Vox Sang; 1985; 49(2):101-9. PubMed ID: 4036082 [TBL] [Abstract][Full Text] [Related]
26. The effect of thoracic duct drainage on lymphocyte dynamics and clinical symptoms in patients with rheumatoid arthritis. Ueo T; Tanaka S; Tominaga Y; Ogawa H; Sakurami T Arthritis Rheum; 1979 Dec; 22(12):1405-12. PubMed ID: 518724 [TBL] [Abstract][Full Text] [Related]
32. Immunomodulating therapy of rheumatoid arthritis by high-dose intravenous immunoglobulin. Becker H; Mitropoulou G; Helmke K Klin Wochenschr; 1989 Mar; 67(5):286-90. PubMed ID: 2565412 [TBL] [Abstract][Full Text] [Related]
33. A randomised, blinded, placebo-controlled, dose escalation study of the tolerability and efficacy of filgrastim for haemopoietic stem cell mobilisation in patients with severe active rheumatoid arthritis. Snowden JA; Biggs JC; Milliken ST; Fuller A; Staniforth D; Passuello F; Renwick J; Brooks PM Bone Marrow Transplant; 1998 Dec; 22(11):1035-41. PubMed ID: 9877264 [TBL] [Abstract][Full Text] [Related]
34. [Therapeutic lymphapheresis in leukostasis-induced priapism]. Strobel E; Howe J; Bäcker U; Ernst G; Mempel M Dtsch Med Wochenschr; 1987 Dec; 112(51-52):1984-5. PubMed ID: 3691330 [TBL] [Abstract][Full Text] [Related]
35. Leukapheresis in rheumatoid arthritis. Association of clinical improvement with reversal of anergy. Wahl SM; Wilder RL; Katona IM; Wahl LM; Allen JB; Scher I; Decker JL Arthritis Rheum; 1983 Sep; 26(9):1076-84. PubMed ID: 6615562 [TBL] [Abstract][Full Text] [Related]
36. The current status of therapeutic apheresis in the management of rheumatoid arthritis. Wallace DJ; Goldfinger D; Klinenberg JR Prog Clin Biol Res; 1982; 106():27-32. PubMed ID: 6757943 [No Abstract] [Full Text] [Related]
38. Leukocytapheresis and rheumatoid arthritis: comment on the article by Hidaka et al. Wallace DJ Arthritis Rheum; 1999 Oct; 42(10):2255-6. PubMed ID: 10524704 [No Abstract] [Full Text] [Related]
39. Leukapheresis and pathogenetic mechanisms in rheumatoid arthritis. Wilder RL; Malone DG; Yarboro CH; Berkebile C; Haraoui B; Allen JB; Wahl SM J Clin Apher; 1984; 2(1):112-8. PubMed ID: 6336086 [TBL] [Abstract][Full Text] [Related]